MediciNova
MNOV
45 hedge funds and large institutions have $45.8M invested in MediciNova in 2017 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 15 increasing their positions, 17 reducing their positions, and 7 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1.1% less ownership
Funds ownership: 23.26% → 22.16% (-1.1%)
5% less capital invested
Capital invested by funds: $48.4M → $45.8M (-$2.6M)
12% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 17
15% less funds holding
Funds holding: 53 → 45 (-8)
57% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 7
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $240K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$11.8M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$193K |
| 3 |
SG Americas Securities
New York
|
+$114K |
| 4 |
BF
Blankinship & Foster
Solana Beach,
California
|
+$94.6K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$86.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.13M |
| 2 |
D.E. Shaw & Co
New York
|
-$343K |
| 3 |
Morgan Stanley
New York
|
-$284K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$262K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$256K |
MNOV Hedge Fund Activity: Q1 2017 in Review
45 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in MediciNova (MNOV) for Q1 2017, worth a combined $45.8M — down 5.4% from $48.4M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of MNOV and 3 opened new positions — a net loss of 4 holders — while 17 trimmed existing stakes and 15 added.
The largest buyer was BlackRock, adding an estimated $11.8M. The largest seller was Fidelity Investments, cutting an estimated $1.13M.
- 45 institutional investors held MediciNova (MNOV) as of Q1 2017, down from 53 in Q4 2016.
- Funds reported $45.8M of MediciNova stock for Q1 2017, down 5.4% quarter-over-quarter.
- 3 funds opened new MediciNova positions in Q1 2017 and 7 closed out, a net change of -4 holders.
- The largest MediciNova buyer in Q1 2017 was BlackRock, an estimated $11.8M added.
- The largest MediciNova seller in Q1 2017 was Fidelity Investments, an estimated $1.13M sold.
Based on aggregated 13F filings for Q1 2017.